Cathay Biotech Inc. (SHA: 688065)

Cathay Biotech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	4,635	5,390	6,295	9,629	5,710	366.38
Trading Asset Securities	0.47	0.47	0.47	0.47	1,330	859.22
Cash & Short-Term Investments	4,635	5,391	6,295	9,629	7,040	1,226
Cash Growth	-24.84%	-14.37%	-34.62%	36.78%	474.41%	288.23%
Accounts Receivable	497.3	385.52	463.56	275.22	294.95	243.53
Other Receivables	7.01	10.35	11.79	6.58	8.32	6.98
Receivables	504.32	395.88	475.35	281.8	303.27	250.51
Inventory	1,329	1,466	1,574	1,185	775.1	830.14
Prepaid Expenses	5.42	-	-	-	0.14	18.47
Other Current Assets	353.35	317.75	131.44	298.68	325.91	381.76
Total Current Assets	6,827	7,571	8,475	11,395	8,444	2,706
Property, Plant & Equipment	9,651	9,376	6,670	2,969	2,789	2,903
Long-Term Investments	138.92	142.73	49.51	53.21	56.18	59.79
Other Intangible Assets	694.28	703.85	777.87	768.46	228.44	231.1
Long-Term Deferred Tax Assets	172.82	158.88	88.28	52.2	36.65	41.23
Long-Term Deferred Charges	6.92	4.98	7.17	9.58	7.87	9.97
Other Long-Term Assets	831.35	876.48	1,759	938.51	572.25	29.89
Total Assets	18,323	18,833	17,827	16,185	12,135	5,982
Accounts Payable	191.01	167.85	240.08	248.83	205.25	687.81
Accrued Expenses	36.77	34.39	32.47	42.34	35.66	42.11
Short-Term Debt	698.92	746.25	161.47	743.51	-	177.79
Current Portion of Long-Term Debt	34.75	784.37	5.38	-	-	42.45
Current Income Taxes Payable	15.3	55.54	30.7	45.4	19.28	0.46
Current Unearned Revenue	12.87	10.48	17.81	14.64	19.9	15.07
Other Current Liabilities	1,465	1,611	936.28	123.01	154.68	74.38
Total Current Liabilities	2,454	3,410	1,424	1,218	434.77	1,040
Long-Term Debt	577.51	245.33	960.5	-	-	80
Long-Term Unearned Revenue	400.15	405.18	404.39	293.03	214.6	218.64
Long-Term Deferred Tax Liabilities	-	-	-	-	1.37	1.21
Total Liabilities	3,432	4,060	2,789	1,511	650.74	1,340
Common Stock	583.38	583.38	583.28	416.68	416.68	375.01
Additional Paid-In Capital	8,529	8,526	8,540	8,688	8,681	3,443
Retained Earnings	2,304	2,167	1,905	1,539	1,278	820.27
Treasury Stock	-144.12	-126.19	-94.67	-	-	-
Comprensive Income & Other	12.84	14.45	14.69	8.23	8.68	3.93
Total Common Equity	11,285	11,164	10,949	10,652	10,385	4,642
Minority Interest	3,606	3,609	4,089	4,022	1,100	-
Shareholders' Equity	14,891	14,773	15,038	14,674	11,484	4,642
Total Liabilities & Equity	18,323	18,833	17,827	16,185	12,135	5,982
Total Debt	1,311	1,776	1,127	743.51	-	300.24
Net Cash (Debt)	3,324	3,615	5,168	8,886	7,040	925.35
Net Cash Growth	-29.32%	-30.05%	-41.84%	26.22%	660.78%	393.03%
Net Cash Per Share	5.72	6.21	8.87	15.24	12.97	1.82
Filing Date Shares Outstanding	593.54	581.32	582.15	583.35	583.35	525.02
Total Common Shares Outstanding	593.54	581.68	582.15	583.35	583.35	525.02
Working Capital	4,373	4,161	7,051	10,177	8,010	1,666
Book Value Per Share	19.01	19.19	18.81	18.26	17.80	8.84
Tangible Book Value	10,591	10,460	10,171	9,883	10,156	4,411
Tangible Book Value Per Share	17.84	17.98	17.47	16.94	17.41	8.40
Buildings	1,967	1,815	1,357	988.18	599.56	605.5
Machinery	3,290	3,216	2,979	1,807	1,002	1,010
Construction In Progress	5,642	5,443	3,164	758.31	1,610	1,598

Source: S&P Capital IQ. Standard template. Financial Sources.